Recognify Life Sciences Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Recognify Life Sciences General Information

Description

Operator of a biotech company intended to transform the treatment of cognitive impairment. The company develops pharmaceutical therapies that modulate the excitatory/inhibitory balance in the brain to improve learning and memory, enabling healthcare providers to treat cognitive impairment associated with schizophrenia, Alzheimer's, and other neurodegenerative and neurocognitive diseases.

Contact Information

Formerly Known As
FSV7
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Berlin
  • Germany
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • Berlin
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Recognify Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 07-Oct-2026 Completed Clinical Trials - Phase 2
2. Merger/Acquisition 06-Nov-2020 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 02-Nov-2020 $25.8M $25.8M Completed Clinical Trials - Phase 2
To view Recognify Life Sciences’s complete valuation and funding history, request access »

Recognify Life Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Recognify Life Sciences’s complete cap table history, request access »

Recognify Life Sciences Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
AtaiBeckley Corporation Majority
Catalio Capital Management Venture Capital Minority
To view Recognify Life Sciences’s complete investors history, request access »

Recognify Life Sciences FAQs

  • When was Recognify Life Sciences founded?

    Recognify Life Sciences was founded in 2018.

  • Where is Recognify Life Sciences headquartered?

    Recognify Life Sciences is headquartered in Berlin, Germany.

  • What industry is Recognify Life Sciences in?

    Recognify Life Sciences’s primary industry is Drug Discovery.

  • Is Recognify Life Sciences a private or public company?

    Recognify Life Sciences is a Private company.

  • What is Recognify Life Sciences’s current revenue?

    The current revenue for Recognify Life Sciences is .

  • How much funding has Recognify Life Sciences raised over time?

    Recognify Life Sciences has raised $25.8M.

  • Who are Recognify Life Sciences’s investors?

    AtaiBeckley and Catalio Capital Management have invested in Recognify Life Sciences.

  • When was Recognify Life Sciences acquired?

    Recognify Life Sciences was acquired on 07-Oct-2026.

  • Who acquired Recognify Life Sciences?

    Recognify Life Sciences was acquired by AmyriAD.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process